Barbeŕa M, Sanjuán J, Munárriz M, Novella E, Santiago C, Simó M
Servicio de Psiquiatria Hospital La Fe Valencia, Spain.
Actas Esp Psiquiatr. 2006 Sep-Oct;34(5):287-94.
The subjective experience of psychotic patients with neuroleptics has been the purpose of many studies, considering its importance in treatment adherence, quality of life and outcome. Many authors have developed measurement instruments applicable in everyday clinical practice. The scale objectives defer in hues, but have the subjective perspective in common.
Questionnaires designed for evaluating subjective experience with antipsychotics, appearing in PUBMED during the last 40 years, have been collected.
Ten scales for evaluating the subjective experience with antipsychotics: NDS, DRI, DAI-30, DAI-10, ROMI, SWN, SWN (short version), MARS, ANT and PETiT, were found. Their advantages and limitations have been analyzed.
We have checked out that the contents of each scale do not overlap. It is proposed to differentiate between ((dysphoria response to neuroleptics)) as an acute effect and the ((subjective experience)) as complex effect of long term compliance.
鉴于其在治疗依从性、生活质量和治疗结果方面的重要性,许多研究都围绕着精神病患者使用抗精神病药物的主观体验展开。许多作者开发了适用于日常临床实践的测量工具。这些量表的目标各有不同,但都有主观视角这一共同点。
收集了过去40年在PubMed上出现的用于评估抗精神病药物主观体验的问卷。
发现了10种用于评估抗精神病药物主观体验的量表:NDS、DRI、DAI - 30、DAI - 10、ROMI、SWN、SWN(简短版)、MARS、ANT和PETiT。分析了它们的优点和局限性。
我们发现各量表的内容并不重叠。建议区分作为急性效应的“抗精神病药物烦躁反应”和作为长期依从性复杂效应的“主观体验”。